Should You Invest in Qiagen NV (QGEN) Now?
Qiagen NV (NYSE: QGEN) has a higher price-to-earnings ratio of 117.04x compared to its average ratio, The 36-month beta value for QGEN is at 0.37.
Qiagen NV (NYSE: QGEN) has a higher price-to-earnings ratio of 117.04x compared to its average ratio, The 36-month beta value for QGEN is at 0.37.
Qiagen NV (NYSE: QGEN) has a price-to-earnings ratio that is above its average at 112.14x. The stock has a 36-month beta value of 0.36. Opinions
Qiagen NV (NYSE: QGEN) has a higher price-to-earnings ratio of 110.06x compared to its average ratio. QGEN has 36-month beta value of 0.37. Analysts have
© 2024, Powered by Smart TechOne
This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.
Strictly Necessary Cookie should be enabled at all times so that we can save your preferences for cookie settings.
If you disable this cookie, we will not be able to save your preferences. This means that every time you visit this website you will need to enable or disable cookies again.